Managing addiction as a chronic condition

Michael Dennis, Christy K Scott, Michael Dennis, Christy K Scott

Abstract

This article reviews progress in adapting addiction treatment to respond more fully to the chronic nature of most patients' problems. After reviewing evidence that the natural history of addiction involves recurrent cycles of relapse and recovery, we discuss emerging approaches to recovery management, including techniques for improving the continuity of care, monitoring during periods of abstinence, and early reintervention; recent developments in the field related to self-management, mutual aid, and other recovery supports; and system-level interventions. We also address the importance of adjusting treatment funding and organizational structures to better meet the needs of individuals with a chronic disease.

Figures

FIGURE 1
FIGURE 1
Substance Use Disorders Begin in Adolescence and Last for Decades In the U.S. household population in 2001, the percentage of people who reported substance dependence or abuse rose through the adolescent age groups to peak among the 18-to 2o-year-olds, and declined through subsequent age groups (OAS, 2002).
FIGURE 2
FIGURE 2
The Pathway to Recovery Is Cyclical Over a 2-year period, 82 percent of drug users transitioned one or more times between use, incarceration, treatment, and recovery. An average of 32 percent changed every 90 days, with movement in every direction and treatment increasing the likelihood of getting to recovery (Scott, Foss, and Dennis, 2005).
FIGURE 3
FIGURE 3
Time to Readmission to Treatment by Condition. In the 24 months following discharge from an index episode of care, the rate of readmission was higher (64% versus 51%) and the median time to readmission was shorter (376 vs. 600 days) among patients who the received recovery management checkup intervention, compared to controls. [Adapted from Dennis, Scott, and Funk, 2003; with permission from Elsevier.]

References

    1. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Substance Use Disorders: Alcohol, Cocaine, Opioids. Washington, DC: American Psychiatric Association; 1995.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000. Text Revision, DSM-IV-TR.
    1. American Society of Addiction Medicine. Patient Placement Criteria for the Treatment of Substance-Related Disorders. 2d ed. Chevy Chase, MD: American Society of Addiction Medicine; 2001.
    1. Anglin MD, et al. Drug treatment careers: Conceptual overview and clinical, research, and policy applications. In: Tims F, Leukefeld C, Platt J, editors. Relapse and Recovery in Addictions. New Haven, CT: Yale University Press; 2001. pp. 18–39.
    1. Anglin MD, Hser YI, Grella CE. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS) Psychology of Addictive Behaviors. 1997;11(4):308–323.
    1. Brooner RK, et al. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry. 1997;54(1):71–80.
    1. Brown SA. Recovery patterns in adolescent substance abuse. In: Baer JS, Marlatt GA, McMahon J, editors. Addictive Behaviors Across the Life Span: Prevention, Treatment, and Policy Issues. Newbury Park, CA: Sage; 1993. pp. 161–183.
    1. Brown SA, et al. Correlates of success following treatment for adolescent substance abuse. Applied and Preventive Psychology. 1994;3(2):61–73.
    1. Capoccia VA, et al. Making “stone soup”: Improvement in clinic access and retention in addiction treatment. Joint Commission journal on Quality and Patient Safety. 2007;33(2):95–103.
    1. Center for Substance Abuse Treatment. Changing the Conversation: The National Treatment Plan Initiative. Rockville, MD: Department of Health and Human Services; 2000.
    1. Chang L, et al. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. American journal of Psychiatry. 2005;162(2):361–369.
    1. Chang L, et al. Combined and independent effects of chronic marijuana use and HIV on brain metabolites. Journal of Neuroimmune Pharmacology. 2006;1(1):65–76.
    1. Ciliska D, et al. A systematic overview of the effectiveness of home visiting as a delivery strategy for public health nursing interventions. Canadian Journal of Public Health. 1996;87(3):193–198.
    1. Compton WM, Lamb RJ, Fletcher BW. Results of the NIDA treatment demonstration grants’ cocaine workgroup: Characteristics of cocaine users and HIV risk behaviors. Drug and Alcohol Dependence. 1995;37(1):1–6.
    1. Cunningham JA. Resolving alcohol-related problems with and without treatment: The effects of different problem criteria. Journal of Studies on Alcohol. 1999a;60(4):463–466.
    1. Cunningham JA. Untreated remissions from drug use: The predominant pathway. Addictive Behaviors. 1999b;24(2):267–270.
    1. Dawson D. Gender differences in the risk of alcohol dependence: United States, 1992. Addiction. 1996;91(12):1831–1842.
    1. Dennis ML, et al. Changing the focus: The case for recognizing and treating cannabis use disorders. Addiction. 2002;97(Suppl 1):4–15.
    1. Dennis ML, et al. The duration and correlates of addiction and treatment careers. Journal of Substance Abuse Treatment. 2005;28(Suppl 1):S51–S62.
    1. Dennis ML, Foss MA, Scott CK. An 8-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Evaluation Review. 2007;31(6):585–612.
    1. Dennis ML, Scott CK, Funk R. An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders. Evaluation and Program Planning. 2003;26(3):339–352.
    1. Donovan DM. Continuing care: Promoting the maintenance of change. In: Miller WR, Heather N, editors. Treating Addictive Behaviors. 2d ed. New York: Plenum; 1998. pp. 317–336.
    1. Dunbar-Jacob J, Burke LE, Puczynski S. Clinical assessment and management of adherence to medical regimens. In: Nicassio PM, Smith TW, editors. Managing Chronic Illness: A Biopsychosocial Perspective. Washington, DC: American Psychological Association; 1995.
    1. Engel GL. The need for a new medical model: A challenge for biomedicine. Science. 1977;196(4286):129–136.
    1. Engel GL. The clinical application of the biopsychosocial model. American Journal of Psychiatry. 1980;137(5):535–544.
    1. Epstein JF. Substance Dependence, Abuse and Treatment: Findings from the 2000 National Household Survey on Drug Abuse. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2002. DHHS Publication No. SMA 02–3642.
    1. Finch AJ. Starting a Recovery School with CEH Test Hazelden Professional Library: A How to Manual. Center City, MN: Hazelden Foundation; 2005.
    1. Fixsen DL, et al. Louis de la Parte Florida Mental Health Institute, National Implementation Research Network (FMHI Publication No. 231) Tampa, FL: University of South Florida; 2005. Implementation research: A synthesis of the literature.
    1. Ford L, Snowden LR, Walser EJ. Outpatient mental health and the dual-diagnosis patient: Utilization of services and community adjustment. Evaluation and Program Planning. 1991;14(4):291–298.
    1. Fowler JS, et al. Imaging the addicted human brain. Science & Practice Perspectives. 2007;3(2):4–16.
    1. French MT, et al. Benefit-cost analysis of residential and outpatient addiction treatment in the state of Washington. Evaluation Review. 2000;24(6):609–634.
    1. Garnick DW, et al. Establishing the feasibility of performance measures for alcohol and other drugs. Journal of Substance Abuse Treatment. 2002;23(4):375–385.
    1. Gilbert FS. The effect of type of aftercare follow-up on treatment outcome among alcoholics. Journal of Studies on Alcohol. 1988;49(2):149–159.
    1. Godley MD, et al. Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment. Journal of Substance Abuse Treatment. 2002;23(1):21–32.
    1. Godley MD, et al. Findings from the assertive continuing care experiment with adolescents with substance use disorders. In: Dewey W, editor. Problems of Drug Dependence, 2003: Proceedings of the 65th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. NIDA Research Monograph Series No. 184; Rockville, MD: National Institute on Drug Abuse; 2004. pp. 123–124.
    1. Godley MD, et al. The effect of assertive continuing care (ACC) on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction. 2007;102(1):81–93.
    1. Godley SH, Godley MD, Dennis ML. The assertive aftercare protocol for adolescent substance abusers. In: Wagner E, Waldron H, editors. Innovations in Adolescent Substance Abuse Interventions. New York: Elsevier; 2001. pp. 311–329.
    1. Grant BF. Theoretical and observed subtypes of DSM-IV alcohol abuse and dependence in a general population sample. Drug and Alcohol Dependence. 2000;60(3):287–293.
    1. Grella CE, Joshi V. Gender differences in drug treatment careers among clients in the National Drug Abuse Treatment Outcome Study. American Journal of Drug and Alcohol Abuse. 1999;25(3):385–406.
    1. Hasin DS, et al. Alcohol dependence and abuse diagnoses: Validity in community sample heavy drinkers. Alcoholism: Clinical and Experimental Research. 1997a;21(2):213–219.
    1. Hasin DS, et al. Differentiating DSM-IV alcohol dependence and abuse by course: Community heavy drinkers. Journal of Substance Abuse. 1997b;9:127–135.
    1. Hien D, et al. Dual diagnosis subtypes in urban substance abuse and mental health clinics. Psychiatric Services. 1997;48(8):1058–1063.
    1. Higgins ST, Badger GJ, Budney AJ. Initial abstinence and success in achieving longer term cocaine abstinence. Experimental and Clinical Psychopharmacology. 2000;8(3):377–386.
    1. Hser YI. Drug treatment careers: A conceptual framework and existing research findings. Journal of Substance Abuse Treatment. 1997;14(6):543–558.
    1. Hser YI, et al. Relationships between drug treatment careers and outcomes: Findings from the National Drug Abuse Treatment Outcome Study. Evaluation Review. 1998;22(4):496–519.
    1. Hser YI, et al. A 33-year follow-up of narcotics addicts. Archives of General Psychiatry. 2001;58(5):503–508.
    1. Hsieh S, Hoffman NG, Hollister CD. The relationship between pre-, during-, post-treatment factors, and adolescent substance abuse behaviors. Addictive Behaviors. 1998;23(4):477–488.
    1. Huber DL. Disease Management: A Guide for Case Managers. Amsterdam: Elsevier; 2005.
    1. Humphreys K, Moos R. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research. 2001;25(5):711–716.
    1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
    1. Ito J, Donovan DM. Aftercare in alcoholism treatment: A review. In: Miller WR, Heather N, editors. Treating Addictive Behaviors: Process of Change. New York: Plenum; 1986. pp. 435–452.
    1. Jaffe J. The concept of dependence: Historical reflections. Alcohol Health and Research World. 1993;17(3):188–189.
    1. Kelly JF, Myers MG. Adolescent treatment outcome in relation to 12-step group attendance. Alcoholism: Clinical and Experimental Research. 1997;21:27A.
    1. Kelly JF, Myers MG, Brown SA. Do adolescents affiliate with 12-step groups? A multivariate process model of effects. Journal of Studies on Alcohol. 2002;63(3):293–304.
    1. Kessler RC. The National Comorbidity Survey of the United States. International Review of Psychiatry. 1994;6:365–376.
    1. Kessler RC, et al. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry. 1996;66(1):17–31.
    1. Klaw E, Huebsch PD, Humphreys K. Communication patterns in an on-line mutual help group for problem drinkers. Journal of Community Psychology. 2000;28(5):535–546.
    1. Kosten TR, et al. Six-month follow-up of short-term pharmacotherapy for cocaine dependence. American Journal of Addictions. 1992;1:40–49.
    1. Kufahl PR, et al. Neural responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage. 2005;28(4):904–914.
    1. Kypri K, et al. Innovative approaches to intervention for problem drinking. Current Opinion in Psychiatry. 2005;18(3):229–234.
    1. Kyrouz EM, Humphreys K, Loomis C. A review of research on the effectiveness of self-help mutual aid groups. In: White BJ, Madara EJ, editors. American Self-Help Clearinghouse Self-Help Group Sourcebook. 7th ed. Cedar Knolls, NJ: American Self-Help Clearinghouse; 2002. pp. 1–16.
    1. Langenbucher JW, Morgenstern J, Miller KJ. DSM-III, DSM-IV and ICD-10 as severity scales for drug dependence. Drug and Alcohol Dependence. 1995;39(2):139–150.
    1. Laudet AB, et al. Support, mutual aid and recovery from dual diagnosis. Community Mental Health Journal. 2000;36(5):457–476.
    1. Lennox RD, Scott-Lennox JA, Bohlig EM. The cost of depression-complicated alcoholism: Health-care utilization and treatment effectiveness. Journal of Mental Health Administration. 1993;20(2):138–152.
    1. Lennox RD, Scott-Lennox JA, Holder HD. Substance abuse and family illness: Evidence from health care utilization and cost-offset research. Journal of Mental Health Administration. 1992;19(1):83–95.
    1. Lennox RD, Zarkin GA, Bray JW. Latent variable models of alcohol-related constructs. Journal of Substance Abuse. 1996;8(2):241–250.
    1. Lipsey MW, Chapman GL, Landenberger NA. Cognitive-behavioral programs for offenders. Annals of the American Academy of Political and Social Science. 2001;578(1):144–157.
    1. Loveland D, Boyle M. Behavioral Health Recovery Management Clinical Guidelines. Peoria, IL: Fayette Companies; 2005. Recovery Coach and Recovery Planning Manual. .
    1. Mark TL, et al. The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence. 2001;61(2):195–206.
    1. Mark TL, et al. Factors associated with the receipt of treatment following detoxification. Journal of Substance Abuse Treatment. 2003;24(4):299–304.
    1. McCarty D, et al. The Network for the Improvement of Addiction Treatment (NIATx): Enhancing access and retention. Drug and Alcohol Dependence. 2007;88(2–3):138–145.
    1. McCorry F, et al. Developing performance measures for alcohol and other drug services in managed care plans. Journal on Quality Improvement. 2000;26(11):633–643.
    1. McKay JR. Recent developments in alcoholism: The role of continuing care in outpatient alcohol treatment programs. In: Galanter M, editor. Services Research in the Era of Managed Care. Vol. 15. New York: Plenum; 2001. pp. 357–372.
    1. McKay JR, et al. Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse. Journal of Studies on Alcohol. 1998;59(2):152–162.
    1. McKay JR, et al. Evaluation of full versus partial continuum of care in the treatment of publicly funded substance abusers in Washington State. American Journal of Drug and Alcohol Abuse. 2002;28(2):307–338.
    1. McKay JR, et al. The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. Journal of Consulting and Clinical Psychology. 2004;72(6):967–979.
    1. McKay JR, et al. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Archives of General Psychiatry. 2005;62(2):199–207.
    1. McLellan AT. Research…for a Change: Impact Through Customer-Oriented Research. Slides presented at the Blending Addiction Science & Practice: Bridges to the Future conference; Seattle, WA. October 16–17; 2006. .
    1. McLellan AT, et al. Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Archives of General Psychiatry. 1983;40(6):620–625.
    1. McLellan AT, et al. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association. 2000;284(13):1689–1695.
    1. McLellan AT, et al. Reconsidering the evaluation of addiction treatment: From retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100(4):447–458.
    1. Miller WR, et al. A randomized trial of methods to help clinicians learn motivational interviewing. Journal of Consulting and Clinical Psychology. 2004;72(6):1050–1062.
    1. Miller WR, et al. Disseminating evidence-based practices in substance abuse treatment: A review with suggestions. Journal of Substance Abuse Treatment. 2006;31(1):25–39.
    1. Moos R, et al. Outpatient mental health care, self-help groups, and patients’ one-year treatment outcomes. Journal of Clinical Psychology. 2001;57(3):273–287.
    1. Moos RH, Moos BS. Long-term influence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders. Addiction. 2003;98(3):325–327.
    1. Mueser KT, et al. Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophrenia Bulletin. 1990;16(1):31–56.
    1. Murray E, et al. Interactive health communication applications for people with chronic disease. Cochrane Database of Systematic Reviews. 2004;4:CD0004274.
    1. Nicassio PM, Smith TW, editors. Managing Chronic Illness: A Biopsychosocial Perspective. Washington, DC: American Psychological Association; 1995.
    1. Office of Applied Studies. Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2002. DHHS Publication No. SMA 02–3758.
    1. Office of Applied Studies. Treatment Episode Data Set (TEDS): 2002. Discharges from Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005. DHHS Publication No. SMA04–3967.
    1. Ouimette PC, Moos RH, Finney JW. Influence of outpatient treatment and 12-step group involvement on one-year substance abuse treatment outcomes. Journal of Studies on Alcohol. 1998;59(5):513–522.
    1. Parthasarathy S, et al. Utilization and cost impact of integrating substance abuse treatment and primary care. Medical Care. 2003;41(3):357–367.
    1. Paulus MP, Tapert SF, Schuckit MA. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Archives of General Psychiatry. 2005;62(7):761–768.
    1. Peterson KA, et al. Determinants of readmission following inpatient substance abuse treatment: A national study of VA programs. Medical Care. 1994;32(6):535–550.
    1. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol. 1997;58(1):7–29.
    1. Regier DA, et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association. 1990;264(19):2511–2518.
    1. Risinger RC, et al. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage. 2005;26(4):1097–1108.
    1. Ritsher JB, et al. Psychiatric comorbidity, continuing care, and mutual help as predictors of five-year remission from substance use disorders. Journal of Studies on Alcohol. 2002;63(6):709–715.
    1. Ritsher JB, Moos RH, Finney JW. Relationship of treatment orientation and continuing care to remission among substance abuse patients. Psychiatric Services. 2002;53(5):595–601.
    1. Robins LN, Regier DA. Psychiatric Disorders in America. New York: Macmillan; 1991.
    1. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry. 1988;45 (11):1023–1031.
    1. Roter DL, et al. Effectiveness of interventions to improve patient compliance: A meta-analysis. Medical Care. 1998;36(8):1138–1161.
    1. Rounsaville BJ, et al. Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome. Archives of General Psychiatry. 1982;39(2):151–156.
    1. Rounsaville BJ, et al. Prognostic significance of psychopathology in treated opiate addicts: A 2. 5-year follow-up study. Archives of General Psychiatry. 1986;43(8):739–745.
    1. Ryan J, Louderman R, Testa M. Substance Abuse and Child Welfare: Experimenting with Recovery Coaches in Illinois. Urbana, IL: University of Illinois at Urbana-Champaign, Children and Family Research Center; 2003.
    1. Sannibale C, et al. Aftercare attendance and post-treatment functioning of severely substance dependent residential treatment clients. Drug and Alcohol Review. 2003;22(2):181–190.
    1. Schlaepfer TE, et al. Decreased frontal white-matter volume in chronic substance abuse. International Journal of Neuropsychopharmacology. 2006;9(2):147–153.
    1. Scott CK, Dennis ML. Recovery Management Checkups: An Early Re-Intervention Model. Chicago, IL: Chestnut Health Systems; 2003.
    1. Scott CK, Dennis ML, Foss MA. Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry, and recovery. Drug and Alcohol Dependence. 2005;78(3):325–338.
    1. Scott CK, Foss MA, Dennis ML. Pathways in the relapse–treatment–recovery cycle over 3 years. Journal of Substance Abuse Treatment. 2005;28(Suppl 1):S63S72.
    1. Simon GE, et al. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: A randomized control trial. Journal of the American Medical Association. 2004;292(8):935–942.
    1. Simpson DD, Joe GW, Broome KM. A national 5-year follow-up of treatment outcomes for cocaine dependence. Archives of General Psychiatry. 2002;59(6):538–544.
    1. Simpson TL, et al. Telephone self-monitoring among alcohol use disorder patients in early recovery: A randomized study of feasibility and measurement reactivity. Drug and Alcohol Dependence. 2005;79(2):241–250.
    1. Slesnick N, Prestopnik JL. Office versus home-based family therapy for runaway, alcohol abusing adolescents: Examination of factors associated with treatment attendance. Alcoholism Treatment Quarterly. 2004;22(2):3–19.
    1. Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2006. DHHS Publication No. SMA 06-4194.
    1. Taxman F. Supervision—Exploring the dimensions of effectiveness. Federal Probation. 2002;66(2):14–27.
    1. Toll BA, et al. What do Internet-based alcohol treatment websites offer? Cyberpsychology & Behavior. 2003;6(6):581–584.
    1. Volkow ND, Fowler JS, Wang GJ. The addicted human brain: Insights from imaging studies. Journal of Clinical Investigation. 2003;111(10):1444–1451.
    1. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology. 2004;47(Suppl 1):3–13.
    1. Walker R, et al. Length of stay, neuropsychological performance, and aftercare: Influences on alcohol treatment outcome. Journal of Consulting and Clinical Psychology. 1983;51(6):900–911.
    1. Weisner C, et al. Report of the Blue Ribbon Task Force on Health Services Research at the National Institute on Drug Abuse. Rockville, MD: National Institute on Drug Abuse; 2004.
    1. Weisner C, Matzger H, Kaskutas LA. How important is treatment? One-year outcomes of treated and untreated alcohol-dependent individuals. Addiction. 2003;98(7):901–911.
    1. White WL. Pathways from the Culture of Addiction to the Culture of Recovery: A Travel Guide for Addiction Professionals. 2d ed. Center City, MN: Hazelden; 1996.
    1. White WL, et al. It’s time to stop kicking people out of addiction treatment. Counselor. 2005;6(2):12–25.
    1. White WL, Finch AJ. The recovery school movement: Its history and future. Counselor. 2006;7(2):54–57.
    1. Willenbring ML. Integrating care for patients with infectious, psychiatric, and substance use disorders: Concepts and approaches. AIDS. 2005;19(Suppl 3):S227–S237.
    1. Wisdom JP, et al. Addiction treatment agencies’ use of data: A qualitative assessment. Journal of Behavioral Health Services and Research. 2006;33(4):394–407.
    1. Woody GE, Cottler LB, Cacciola J. Severity of dependence: Data from the DSM-IV field trials. Addiction. 1993;88(11):1573–1579.
    1. World Health Organization (WHO) The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) Geneva, Switzerland: World Health Organization; 1999.
    1. Zhu S-H, et al. Telephone counseling for smoking cessation: Effects of single-session and multiple-session interventions. Journal of Consulting and Clinical Psychology. 1996;64(1):202–211.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera